ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Renovaro Inc

Renovaro Inc (RENB)

0.7121
0.0051
(0.72%)
終値: 1月22日 6:00AM
0.7121
0.00
( 0.00% )
取引時間後: 6:02AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
0.7121
買値
0.71
売値
0.7275
出来高
841,517
0.707 日の範囲 0.7596
0.395 52 週間の範囲 5.25
時価総額
前日終値
0.707
始値
0.7072
最終取引時間
06:03:00
財務取引量
US$ 618,086
VWAP
0.73449
平均取引量 (3 か月)
1,074,559
発行済株式数
158,717,342
配当利回り
-
PER
-1.42
1 株当たり利益 (EPS)
-0.51
歳入
-
純利益
-80.65M

Renovaro Inc について

Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer. The company's product pipeline includes ENOB-HV... Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer. The company's product pipeline includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a gene therapy curative treatment for HBV. It develops ENOB-DC-11, an allogeneic dendritic cell therapeutic vaccine for solid tumors; ENOB-DC-12-XX, allogeneic dendritic cell therapeutic vaccine for other solid tumors; and ENOB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. Enochian Biosciences, Inc. has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was formerly known as Enochian Biosciences, Inc. and changed its name to Renovaro Biosciences Inc. in August 2023. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Renovaro Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker RENB. The last closing price for Renovaro was US$0.71. Over the last year, Renovaro shares have traded in a share price range of US$ 0.395 to US$ 5.25.

Renovaro currently has 158,717,342 shares in issue. The market capitalisation of Renovaro is US$112.21 million. Renovaro has a price to earnings ratio (PE ratio) of -1.42.

RENB 最新ニュース

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth Initiatives LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE...

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and decades of longitudinal drug response data Data provides...

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Current Renovaro Chairman to Lead Subsidiary’s Development Program and Commercialization LOS ANGELES and AMSTERDAM, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in...

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

LUMINA is an Advanced Minimal Residual Disease Detection Platform for Lung Cancer Harnessing the Power of Multi-omics Biomarkers and AI LOS ANGELES and AMSTERDAM, Dec. 23, 2024 (GLOBE NEWSWIRE...

Renovaro Regains Compliance with NASDAQ Listing Requirement

LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced that it has...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.2229-23.83957219250.9350.9350.74933610.75642799CS
4-0.3879-35.26363636361.11.280.6714801940.94192186CS
120.180433.92890727850.53172.10.4610745591.17663314CS
26-0.6179-46.45864661651.332.10.3958206500.96062745CS
52-4.0879-85.16458333334.85.250.3956867291.34133464CS
156-0.1579-18.14942528740.875.250.3956381011.55204399CS
260-0.1579-18.14942528740.875.250.3956381011.55204399CS

RENB - Frequently Asked Questions (FAQ)

What is the current Renovaro share price?
The current share price of Renovaro is US$ 0.7121
How many Renovaro shares are in issue?
Renovaro has 158,717,342 shares in issue
What is the market cap of Renovaro?
The market capitalisation of Renovaro is USD 112.21M
What is the 1 year trading range for Renovaro share price?
Renovaro has traded in the range of US$ 0.395 to US$ 5.25 during the past year
What is the PE ratio of Renovaro?
The price to earnings ratio of Renovaro is -1.42
What is the reporting currency for Renovaro?
Renovaro reports financial results in USD
What is the latest annual profit for Renovaro?
The latest annual profit of Renovaro is USD -80.65M
What is the registered address of Renovaro?
The registered address for Renovaro is 108 W. 13TH STREET SUITE 100, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Renovaro website address?
The website address for Renovaro is renovarobio.com
Which industry sector does Renovaro operate in?
Renovaro operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NEHCNew Era Helium Inc
US$ 4.08
(48.91%)
716.34k
NFXLDirexion Daily NFLX Bull 2X Shares
US$ 42.48
(20.51%)
96.48k
BROGBrooge Energy Ltd
US$ 1.51
(17.97%)
18.07k
MKZRMackenzie Realty Capital Inc
US$ 2.48
(14.29%)
277
KDLYKindly MD Inc
US$ 1.63
(13.05%)
2.23k
NFXSDirexion Daily NFLX Bear 1X Shares
US$ 17.95
(-10.70%)
31.2k
MYNAMynaric AG
US$ 0.61
(-8.91%)
296.71k
SNOASonoma Pharmaceuticals Inc
US$ 2.50
(-7.06%)
11.57k
HEPAHepion Pharmaceuticals Inc
US$ 0.30275
(-5.95%)
21.94k
LEDSSemiLEDS Corporation
US$ 1.65
(-5.71%)
4.59k
TLTiShares 20 plus Year Treasury Bond
US$ 87.86
(-0.11%)
3.68M
NVDANVIDIA Corporation
US$ 140.95
(0.09%)
2.45M
GCTKGlucoTrack Inc
US$ 0.13
(6.04%)
1.5M
AMZNAmazon.com Inc
US$ 231.55
(0.36%)
865.27k
NFLXNetflix Inc
US$ 960.59
(10.19%)
812.66k

RENB Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock